# US 6,391,297 B1 · Differentiation of adipose stromal cells into osteoblasts and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,391,297 B1
- Document ID: US6391297B1
- Status: Granted
- Kind: B1
- Application number: 09/554,868
- Filed: 2000-05-19
- Granted: 2002-05-21
- Earliest claimed: 2000-05-19
- Assignees: Artecel Sciences, Inc.
- Inventors: Yuan-di C. Halvorsen
- Web page: https://patentgrep.com/patent/US6391297B1

## CPC

- C12N 5/0654: {Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth}
- A61K 35/32: Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61P 19/10: for osteoporosis
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61F 2/28: Bones
- A61F 2002/2817: {Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]}
- A61F 2002/2835: {Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material}
- A61F 2002/30677: {Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body}
- A61F 2002/4648: {Means for culturing bone graft}
- A61F 2310/00293: containing a phosphorus-containing compound, e.g. apatite
- A61F 2310/00365: Proteins; Polypeptides; Degradation products thereof
- A61F 2310/00383: Gelatin
- A61K 35/12: Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells (vaccines or medicinal preparations containing antigens or antibodies A61K39/00)
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61K 48/00: Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C12N 2500/34: Sugars
- C12N 2500/38: Vitamins
- C12N 2500/42: Organic phosphate, e.g. beta glycerophosphate
- C12N 2501/155: Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
- C12N 2502/1305: Adipocytes
- C12N 2506/13: from connective tissue cells, from mesenchymal cells
- C12N 2506/1384: from adipose-derived stem cells [ADSC], from adipose stromal stem cells
- C12N 2510/00: Genetically modified cells
- C12N 2533/14: Ceramic
- C12N 2533/54: Collagen; Gelatin
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

The invention provides a composition of an isolated human adipose tissue-derived stromal cell that has been differentiated to exhibit at least one characteristic of a non-adipocyte cell lineage wherein the non-adipocyte cell lineage is osteoblastic. The adipose-derived cell possessing an osteoblastic characteristic can be genetically modified or combined with a matrix. The compositions of the invention can be used in vivo to repair bone and treat bone diseases.

## Claims

### Claim 1

An isolated human adipose tissue-derived stromal cell that exhibits at least one characteristic of a non-adipocyte cell lineage, wherein the non-adipocyte cell lineage is osteoblastic.

### Claim 2 (depends on 1)

The human cell of claim 1, wherein the cell is genetically modified.

### Claim 3 (depends on 2)

The human cell of claim 2, wherein the genetic modification is the introduction of a nucleic acid into the cell.

### Claim 4 (depends on 1)

The human cell of claim 1, combination with a matrix.

### Claim 5 (depends on 4)

The human cell of claim 4, wherein the matrix selected from the group consisting of hydroxyapetite/tricalcium phosphate, gelatin, poly-L-lysine, and collagen.

### Claim 6 (depends on 1)

The human cell of claim 1, wherein the cell can be maintained in culture for up to 5 passages.
